Multicenter, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of the Effects of Titrated Oral Tolvaptan Tablets in Patients With Hyponatremia, Study 2.

Trial Profile

Multicenter, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of the Effects of Titrated Oral Tolvaptan Tablets in Patients With Hyponatremia, Study 2.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 May 2012

At a glance

  • Drugs Tolvaptan (Primary)
  • Indications Chronic heart failure; Hyponatraemia
  • Focus Therapeutic Use
  • Acronyms SALT-2
  • Sponsors Otsuka Pharmaceutical Development & Commercialization
  • Most Recent Events

    • 02 May 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT00201994).
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top